10-Year-Results of the prospective German-Austrian Phase II Multicenter study for risk-adapted Radiotherapy of localized Prostate Cancer with a moderate Dose Escalation from 70 to 74 Gy

被引：0
|
作者：
Goldner, G. [1 ]
Bombosch, V. [2 ]
Becker, G. [3 ]
Wachter, S. [4 ]
Glocker, S. [5 ]
Feldmann, H. [6 ]
Bamberg, M. [5 ]
Poetter, R. [2 ]
Molls, M. [7 ]
Geinitz, H. [8 ]
机构：
[1] Med Univ Wien, Klin Strahlentherapie & Biol, Vienna, Austria
[2] Med Univ Wien, Vienna, Austria
[3] Klin Eichert, Goppingen, Germany
[4] Klinikum Passau, Passau, Germany
[5] Univ Klinikum Tubingen, Tubingen, Germany
[6] Stadtklinikum, Fulda, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
[8] Krankenhaus Barmherzigen Schwestern, Linz, Austria
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 25 条
  • [1] Three-dimensional conformal risk-adapted Radiotherapy of localized Prostate Cancer with moderate Dose Escalation from 70 to 74 Gy: 10-Year Results of the prospective German-Austrian Phase-II-Multicenter Study
    Goldner, G.
    Bombosch, V.
    Becker, G.
    Glocker, S.
    Feldmann, H. J.
    Bamberg, M.
    Molls, M.
    Poetter, R.
    Wachter, S.
    Geinitz, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (01) : 117 - 118
  • [2] 3-dimensional conformal risk adaptive radio therapy of localised prostate carcinoma with moderate dose escalation of 70 to 74 Gy: 5-year results of prospective German-Austrian phase-II-multicenter study
    Goldner, G.
    Bombosch, V.
    Geinitz, H.
    Becker, G.
    Wachter, S.
    Glocker, S.
    Zimmermann, F.
    Wachter-Gerstner, N.
    Bamberg, M.
    Molls, M.
    Feldmann, H.
    Poetter, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 32 - 32
  • [3] Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy : FFFirst report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial [Dreidimensionale konformale risikoadaptierte Radiotherapie des lokalisierten Prostatakarzinoms mit moderater Dosiseskalation von 70 auf 74 Gy. 5-Jahres-Resultate der prospektiven österreichisch-deutschen Phase-II-Multicenterstudie]
    Goldner G.
    Bombosch V.
    Geinitz H.
    Becker G.
    Wachter S.
    Glocker S.
    Zimmermann F.
    Wachter-Gerstner N.
    Schrott A.
    Bamberg M.
    Molls M.
    Feldmann H.
    Pötter R.
    Strahlentherapie und Onkologie, 2009, 185 (2) : 94 - 100
  • [4] 10-Year Results of a Phase III Randomized Trial of High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localized Prostate Cancer
    Zapatero, A.
    Guerrero Grande, A. D.
    Maldonado, X., Sr.
    Alvarez, A.
    San Segundo, C. Gonzalez
    Cabeza, M. A.
    Sole, J. M.
    Pedro Olive, A.
    Casas Duran, F.
    Boladeras, A.
    Martin de Vidales, C.
    Vazquez de la Torre, M. L.
    Varas, S.
    Calvo, F. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S77 - S77
  • [5] Preliminary results of a multicenter phase II study on conformal radiotherapy of prostate cancer with risk of adjusted dosage increase to 74 Gy
    Wachter, S
    Wachter-Gerstner, N
    Zimmermann, F
    Geinitz, H
    Goldner, G
    Glocker, S
    Feldmann, HJ
    Becker, G
    Bamberg, M
    Molls, M
    Pötter, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 40 - 40
  • [6] Moderate Dose Escalation in Three-Dimensional Conformal Localized Prostate Cancer Radiotherapy Single-institutional Experience in 398 Patients Comparing 66Gy versus 70Gy versus 74Gy
    Goldner, Gregor
    Dimopoulos, Johannes
    Kirisits, Christian
    Poetter, Richard
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (07) : 438 - 445
  • [7] High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial
    Zapatero, Almudena
    Guerrero, Araceli
    Maldonado, Xavier
    Alvarez, Ana
    Gonzalez San-Segundo, Carmen
    Cabeza Rodriguez, Maria Angeles
    Maria Sole, Josep
    Pedro Olive, Agusti
    Casas, Francesc
    Boladeras, Ana
    Martin de Vidales, Carmen
    Vazquez de la Torre, Maria Luisa
    Vara, Susana
    Luis Sanz, Juan
    Calvo, Felipe A.
    LANCET ONCOLOGY, 2022, 23 (05): : 671 - 681
  • [8] Acute toxicity in 260 patients with locally limited prostate cancer after conformal radiotherapy risk-adjusted up to 74 Gy:: Results of a multicenter phase-II study
    Zimmermann, F
    Geinitz, H
    Wachter, S
    Wachter-Gerstner, N
    Goldner, G
    Glocker, S
    Feldmann, HJ
    Becker, G
    Bamberg, M
    Pötter, R
    Molls, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 21 - 21
  • [9] Results of the German-Austrian multicentre study for 3D-CRT of localised prostate cancer with 70/74 Gy in a follow-up to 7 years:: Biochemical and clinical controls, acute and late toxicity
    Goldner, G.
    Geinitz, H.
    Wachter, S.
    Becker, G.
    Zimmermann, F.
    Wachter-Gerstner, N.
    Tomicek, B.
    Glocker, S.
    Reibenwein, J.
    Feldmann, H.-J.
    Bamberg, M.
    Molls, M.
    Poetter, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 120 - 120
  • [10] Re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial
    Bokhorst, Leonard P.
    Heesterman, Berdine L.
    EUROPEAN UROLOGY, 2022, 82 (04) : 441 - 441
123